Precigen
PGEN
#5405
Rank
โ‚น139.13 B
Marketcap
โ‚น388.04
Share price
-2.58%
Change (1 day)
3.92%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): โ‚น2.50 Billion

According to Precigen's latest financial reports the company's current earnings are โ‚น0.15 Billion. In 2025 the company made an earning of -โ‚น23.38 Billion a decrease over its 2024 earnings that were of -โ‚น11.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.50 B-110.71%
2025 -โ‚น23.38 Billion95.77%
2024 -โ‚น11.95 Billion32.86%
2023 -โ‚น8.99 Billion20.5%
2022 -โ‚น7.46 Billion-23.33%
2021 -โ‚น9.73 Billion60.11%
2020 -โ‚น6.08 Billion-65.1%
2019 -โ‚น17.42 Billion-65.19%
2018 -โ‚น50.02 Billion313.44%
2017 -โ‚น12.1 Billion-33.2%
2016 -โ‚น18.12 Billion123.22%
2015 -โ‚น8.12 Billion1.47%
2014 -โ‚น8 Billion109.54%
2013 -โ‚น3.82 Billion-50.04%
2012 -โ‚น7.64 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-110.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น6.82 Billion-396.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น20.85 Billion-1,008.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น8.4 Billion-465.61% Jersey